平民创伤中冷冻保存浓缩红细胞输注的全国性分析
该研究基于2015—2016年创伤质量改进项目(Trauma Quality Improvement Program)数据库,纳入入院4小时内接受红细胞输注的成人(年龄≥18岁)创伤患者,比较接受CPRBC与LPRBC者的结局。共识别39,975例患者,经倾向性匹配后获得483例匹配队列,其中161例接受CPRBC,322例接受LPRBC。CPRBC组与LPRBC组的24小时死亡率(1.8% vs. 2.3%,p=0.82)、院内死亡率(4.9% vs. 5.2%,p=0.88)及并发症发生率(15.3% vs. 17.2%,p=0.21)均无显著差异。作者认为,在中等程度创伤患者中,CPRBC输注可能不劣于LPRBC,冷冻保存有潜力在用量增加、灾难场景及农村地区等不同环境中扩展输血储备。
要点
- 在中等程度创伤患者中,CPRBC组与LPRBC组的24小时死亡率分别为1.8%与2.3%,差异无统计学意义(p=0.82)。
- CPRBC组与LPRBC组的院内死亡率分别为4.9%与5.2%,差异无统计学意义(p=0.88)。
- CPRBC组与LPRBC组的主要并发症发生率分别为15.3%与17.2%,差异无统计学意义(p=0.21)。
- 匹配队列中CPRBC组输注量中位数为2(2-4)单位,LPRBC组为3(2-6)单位;血浆分别为2(0-5)与3(0-6)单位;血小板均为1(0-2)单位。
- 作者认为,冷冻保存有潜力在用量增加、灾难场景及农村地区等不同环境中扩展输血储备。
适用人群与场景
- 成人(年龄≥18岁)创伤患者,且在入院4小时内接受红细胞输注。
- 匹配队列中平均年龄43±22岁,62%为男性,损伤严重度评分18(12-27),65%为钝性伤。
处置流程与药物剂量
- CPRBC组接受CPRBC中位数2(2-4)单位、血浆2(0-5)单位、血小板1(0-2)单位。
- LPRBC组接受LPRBC中位数3(2-6)单位、血浆3(0-6)单位、血小板1(0-2)单位。
研究设计与关键结果
- 研究类型为基于创伤质量改进项目(2015—2016年)的全国性分析,共识别39,975例患者,经倾向性匹配获得483例匹配队列。
- 匹配队列中161例接受CPRBC,322例接受LPRBC;倾向性匹配调整了人口学特征、生命体征、血液成分、损伤参数、合并症及中心参数。
- 主要终点:24小时死亡率CPRBC组1.8% vs. LPRBC组2.3%(p=0.82),院内死亡率CPRBC组4.9% vs. LPRBC组5.2%(p=0.88),均无显著差异。
- 次要终点:主要并发症发生率CPRBC组15.3% vs. LPRBC组17.2%(p=0.21),无显著差异。
证据类型、等级与局限
- 证据类型:治疗性研究,证据等级III级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在中等程度创伤患者中,CPRBC输注可能和LPRBC输注一样安全有效。
- 作者认为,冷冻保存有潜力在用量增加、灾难场景及农村地区等不同环境中扩展输血储备。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Liquid packed red blood cells (LPRBCs) have a limited shelf life and worsening quality with age. Cryopreserved packed red blood cells (CPRBCs) can be stored up to 10 years with no quality deterioration. The effect of CPRBCs on outcomes in civilian trauma is less explored. This study aims to evaluate the safety and efficacy of CPRBCs in civilian trauma patients.
METHODS: We analyzed the (2015-2016) Trauma Quality Improvement Program, including adult (age, ≥18 years) patients who received a RBC transfusion within 4 hours of admission. Patients were stratified, those who received LPRBC and those who received CPRBC. Primary outcomes were 24-hour and in-hospital mortality. Secondary outcomes were major complications. Propensity matching was performed adjusting for demographics, vitals, blood components, injury parameters, comorbidities, and center parameters.
RESULTS: A total of 39,975 patients were identified, and a matched cohort of 483 was obtained. A total of 161 received CPRBC (CPRBC, 2 [2-4]; plasma, 2 [0-5]; platelets, 1 [0-2]) and 322 received LPRBC (LPRBC, 3 [2-6]; plasma, 3 [0-6]; platelets, 1 [0-2]). The mean age was 43 ± 22 years, 62% were men, Injury Severity Score was 18 (12-27), and 65% had a blunt injury. Patients who received CPRBC had similar 24-hour mortality (1.8% vs. 2.3%; p = 0.82) and in-hospital mortality (4.9% vs. 5.2%; p = 0.88). No difference was found in terms of complications (15.3% vs. 17.2%; p = 0.21) between the two groups.
CONCLUSION: Transfusion of CPRBCs may be as safe and effective as transfusion of LPRBCs in moderately injured trauma patients. Cryopreservation has the potential to expand our transfusion armamentarium in diverse settings, such as periods of increased usage, disaster scenarios, and rural areas.
LEVEL OF EVIDENCE: Therapeutic study, level III.
参考来源
- Hanna K, Chehab M, Bible L, et al. Nationwide analysis of cryopreserved packed red blood cell transfusion in civilian trauma. J Trauma Acute Care Surg. 2020. PMID: 32366762. doi:10.1097/TA.0000000000002711
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。